My Profile e-Learning Center my.ASTHO Contact Us

Displaying 5 results for

Search within results:

GO

Search Filters: Opioids Social and Behavioral Health HIV

Public Health Policy Issues to Watch in 2021

Blog,

Health Policy Update,

Policy,

State Health Policy,

Infectious Disease,

COVID-19,

COVID Vaccine,

COVID and Community Mitigation,

COVID and Law/Policy,

Immunization,

Vaccine Distribution,

Vaccine Hesitancy,

Influenza,

Leadership and Workforce Development,

Population Health and Prevention,

Social and Behavioral Health,

STIs,

HIV,

Tobacco Control,

Substance Misuse,

Opioids,

Overdose Prevention,

Women, Infant, and Family Health,

Maternal Morbidity and Mortality,

Risk-Appropriate Care,

Public Health Law,

Preparedness,

Emergency Powers,

Health Equity,

Rural Health,

Healthcare Access,

Andy Baker-White,

Beth Giambrone,

Maggie Davis,

Environmental Health,

Food and Water Safety,

PFAS,

Evidence or Fact-Based Measures

With many of the state and territorial legislatures reconvening over the next few weeks, we can look forward to new (and not-so-new) legislation start to crop up that will impact public health. To help navigate the new legislative ...

State Legislative Activity Supports Federal Evidence-Based HIV Prevention Initiative

Blog,

Health Policy Update,

Infectious Disease,

Population Health and Prevention,

Social and Behavioral Health,

STIs,

HIV,

Substance Misuse,

Opioids,

Arizona,

California,

Colorado,

Connecticut,

Delaware,

Illinois,

Kentucky,

Massachusetts,

Missouri,

New Jersey,

New York,

Oregon,

Rhode Island,

Virginia,

Policy,

State Health Policy,

Rachel Scheckman,

LGBTQ+,

Evidence or Fact-Based Measures,

Syndemic-Related Infections

Across the nation, public health agencies have mounted herculean efforts to stem the COVID-19 pandemic while addressing a pre-existing HIV epidemic and an opioid crisis that is serving as a source for many new HIV outbreaks. Tackling these ...

Top Nine Public Health Highlights of 2019

Blog,

People of Public Health,

Advocacy,

Washington Week,

Population Health and Prevention,

Social and Behavioral Health,

STIs,

HIV,

Substance Misuse,

Opioids,

Tobacco Control,

Leadership and Workforce Development,

Members,

Policy,

Federal Government Affairs,

Territorial Health Policy,

Environmental Health,

Climate and Health,

Infectious Disease,

Territories and Freely Associated States,

Public Health Infrastructure and Systems Improvement,

Funding,

Michael Fraser,

Nathaniel Smith,

John Wiesman,

Ngozi Ezike,

Joneigh Khaldun,

Elizabeth Cuervo Tilson,

Lee Norman,

Monica Bharel,

Renee Coleman Mitchell,

Esther L. Muña,

Linda Denourcey,

Karyl Thomas Rattay

ASTHO CEO Michael Fraser looks back on nine of the top public health highlights in 2019.

Seeing the Possible: A Conversation With CDC Director Robert Redfield

Podcast,

Infectious Disease,

Population Health and Prevention,

Social and Behavioral Health,

STIs,

HIV,

Immunization,

Vaccine Distribution,

COVID-19,

COVID Vaccine,

COVID and Communication,

Robert Johnson,

Robert R. Redfield,

Substance Misuse,

Opioids,

Syndemic-Related Infections,

Public Health Review

In this wide-ranging conversation, Robert Redfield, MD, shares insights into how his own personal experiences have shaped his priorities as CDC director, the importance of improved communication around vaccine education, CDC’s strategy to ...

2023 Legislative Session Update: Part One

Blog,

Health Policy Update,

Policy,

State Health Policy,

Territorial Health Policy,

Population Health and Prevention,

Social and Behavioral Health,

Mental Health,

STIs,

HIV,

Substance Misuse,

Opioids,

Tobacco Control,

Environmental Health,

Food and Water Safety,

PFAS,

Florida,

Guam,

Hawaii,

Illinois,

Indiana,

Kentucky,

Mississippi,

New Mexico,

New York,

Oklahoma,

South Dakota,

Utah,

Vermont,

Virginia,

West Virginia,

Beth Giambrone,

Christina Severin,

Parker Beene,

Maggie Davis

A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: tobacco, HIV, mental health, PFAS, and opioids.